BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 17156769)

  • 1. Anion gap among patients of multiple myeloma and normal individuals.
    Mansoor S; Siddiqui I; Adil S; Nabi Kakepoto G; Fatmi Z; Ghani F
    Clin Biochem; 2007 Feb; 40(3-4):226-9. PubMed ID: 17156769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lower anion gap increases sensitivity in predicting elevated lactate.
    Singh RN; Singh NC; Hutchison J; Moses GC
    Clin Intensive Care; 1994; 5(5):221-4. PubMed ID: 10150548
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frequency of hypercalcemia in patients of multiple myeloma in Karachi.
    Mansoor S; Siddiqui I; Adil S; Kakapeto GN; Fatmi Z
    J Coll Physicians Surg Pak; 2005 Jul; 15(7):409-12. PubMed ID: 16197869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of serum anion gap in patients with HIV.
    Al-Aly Z; Valdez H; Moiz A; Bastani B
    J Nephrol; 2007; 20(6):727-30. PubMed ID: 18046675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of serum anion gap in patients with liver cirrhosis of diverse etiologies.
    Hassan H; Joh JH; Bacon BR; Bastani B
    Mt Sinai J Med; 2004 Sep; 71(4):281-4. PubMed ID: 15365595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A dynamic observation on serum cytokine and immunoglobulin (IgG, IgA, IgM) in patients with esophageal cancer].
    Tang RG; Yuan XH; Tang TT; Tang XQ; Hang YQ; Qin HJ; Chen HM; Fang WZ; Long XK
    Zhonghua Yu Fang Yi Xue Za Zhi; 2007 Jun; 41 Suppl():35-8. PubMed ID: 17767855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in serum anion gap and sodium level in monoclonal gammopathies.
    Nanji AA; Halstead AC
    Can Med Assoc J; 1982 Jul; 127(1):32-5. PubMed ID: 7083108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pseudohyponatremia and anion gap changes in multiple myeloma].
    Valdivieso A; Costa M; Robino X; Quiroga T; Bertin P
    Rev Med Chil; 1989 Jun; 116(6):559-62. PubMed ID: 2749041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum sialic acid in patients with multiple myeloma.
    Crook MA; Couchman S; Tutt P
    Br J Biomed Sci; 1996 Sep; 53(3):185-6. PubMed ID: 8914343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Isotypic characterization of IgA paraproteins: association with other clinical and analytic data].
    González González JB; García Delgado R; Cámara Sáez E; Ortiz Maslloréns F
    Rev Clin Esp; 1996 Aug; 196(8):529-35. PubMed ID: 8984539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prognostic factors affecting survival in multiple myeloma].
    Tornóczky J; Tóth A; Sziládi E; Hoffmann E; Liszátz M
    Orv Hetil; 1990 Aug; 131(31):1679-84. PubMed ID: 2205822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Diagnosis delay of multiple myeloma: report of 22 cases in an internal medicine department of Dakar].
    Pouye A; Ka MM; Dia D; Guéye N; Diallo S; Ndongo S; Lèye AN; Diop T
    Dakar Med; 2004; 49(2):132-5. PubMed ID: 15786624
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prognostic value of the new international staging system in multiple myeloma. Comparison with Durie-Salmon staging system].
    Conté L G; Figueroa M G; Lois V V; Cabrera C ME; León R A; García L H; Rojas R H
    Rev Med Chil; 2008 Jan; 136(1):7-12. PubMed ID: 18483648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic factors and staging systems of multiple myeloma:
    Tao ZF; Fu WJ; Yuan ZG; Wang DX; Chen YB; Hou J
    Chin Med J (Engl); 2007 Oct; 120(19):1655-8. PubMed ID: 17935664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aberrant glycosylation of Igg heavy chain in multiple myeloma.
    Aurer I; Lauc G; Dumić J; Rendić D; Matisić D; Milos M; Heffer-Lauc M; Flogel M; Labar B
    Coll Antropol; 2007 Mar; 31(1):247-51. PubMed ID: 17598409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum concentrations of DKK-1 correlate with the extent of bone disease in patients with multiple myeloma.
    Kaiser M; Mieth M; Liebisch P; Oberländer R; Rademacher J; Jakob C; Kleeberg L; Fleissner C; Braendle E; Peters M; Stover D; Sezer O; Heider U
    Eur J Haematol; 2008 Jun; 80(6):490-4. PubMed ID: 18331598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Evaluation of a morphologic staging method (myeloma progression score) in multiple myeloma].
    Pasqualetti P; Casale R; Collacciani A; Colantonio D
    Medicina (Firenze); 1989; 9(3):280-2. PubMed ID: 2615598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum levels of interleukin-15 and interleukin-10 and their correlation with proliferating cell nuclear antigen in multiple myeloma.
    Pappa C; Miyakis S; Tsirakis G; Sfiridaki A; Alegakis A; Kafousi M; Stathopoulos EN; Alexandrakis MG
    Cytokine; 2007 Feb; 37(2):171-5. PubMed ID: 17446083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proposal and validation of prognostic scoring systems for IgG and IgA monoclonal gammopathies of undetermined significance.
    Rossi F; Petrucci MT; Guffanti A; Marcheselli L; Rossi D; Callea V; Vincenzo F; De Muro M; Baraldi A; Villani O; Musto P; Bacigalupo A; Gaidano G; Avvisati G; Goldaniga M; Depaoli L; Baldini L
    Clin Cancer Res; 2009 Jul; 15(13):4439-45. PubMed ID: 19509142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Expression and clinical significance of beta-catenin in multiple myeloma].
    Li J; Zhang DB; Luo SK; Zhao Y; Huang BH; Gu JL
    Ai Zheng; 2007 Sep; 26(9):1010-4. PubMed ID: 17927863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.